DURHAM – Fortrea, the huge life science contract resource organization spun off from Labcorp, has a new leader for its consulting group: Veteran executive John Doyle.
Fortrea announced the hire on Friday.
“Pharmaceutical and biotechnology innovators must constantly navigate complex and fast-changing business and regulatory environments to achieve their mission,” said Tom Pike, chairman and chief executive officer of Fortrea, in the announcement. “John has extensive industry knowledge and distinctive technical skills that translate to tremendous value for customers. He brings an impressive track record of building and operating differentiated consulting organizations that drive innovation and growth. John is taking the helm of a truly talented team of experts with deep knowledge of scientific methods and regulatory requirements in jurisdictions around the world. I’m confident they will deliver solutions that bring life changing treatments to patients faster.”
The consulting group includes drug development, commercialization and market access advisors with scientific, regulatory and operational expertise spanning more than 13 countries, Fortrea says.
Labcorp spin offs Fortrea, creating 19,000-employee life science firm based in Durham
“The biopharma industry is relentless in advancing science to improve patient outcomes and Fortrea is uniquely positioned to help,” Doyle said. “I’m honored to be a part of Fortrea and excited to join at such a pivotal time in the first few months of the company’s launch. Elevating Fortrea’s Consulting capabilities will add to the momentum and leverage Fortrea’s leading capabilities to create innovative solutions for our customers.”
Doyle most recently worked at Exponent, a Silicon Valley-based scientific and engineering consulting firm where he led the health sciences group. He also formerly led Pfizer’s Global Healthcare Innovation Center.
